Decision Resources, one of the
world’s leading research and advisory firms focusing on pharmaceutical and
healthcare issues, finds that in the U.S., the prevalence of major
depression is closely correlated with ethnic status — Whites have a higher
rate of depression, whereas Hispanics generally have lower rates.
The new analytics tool entitled PatientFinder: Major Depression
estimates that states with larger-than-average Hispanic populations have
some of the lowest prevalent rates of major depression. California, Texas,
Arizona and Florida are four of the five states with the lowest prevalent
rates of depression (5 percent or less of the population). Research
indicates that Hispanics tend to have lower treatment rates for depression
than do other ethnicities.
"Despite their low overall prevalence, states like California actually
have some of the highest numbers of untreated patients and remain an
excellent territory for growing market share of brands that treat
depression," stated Jason LaBonte, Ph.D., Vice President of New Product
Development at Decision Resources.
Why Pharmaceutical Companies Need this Information
With the type of information included in PatientFinder, pharmaceutical
organizations can identify the local markets that offer the greatest
opportunity for their branded drug. Companies can identify markets that are
underserved and determine if they should increase direct-to-consumer
advertising, work with the local managed care organizations to increase
awareness of the disease and benefits of their drug or align sales
representatives to maximize market potential.
About PatientFinder
PatientFinder is the only healthcare analytics tool that assesses local
markets for expansion opportunity by determining the number of insured
patients in each territory who have the disease but are untreated.
PatientFinder covers each of the 50 U.S. states and 318 U.S. metropolitan
statistical areas (MSAs) and provides:
– Disease-specific prevalence numbers for each U.S. state and MSA
– Examination of treatment rates for the disease population to create
percent treated and percent untreated estimates by state and MSA
– Unique analysis of the untreated population examined through a
filter of prescription (Buy lasix pills Rx) benefit coverage. The end result is an estimate
of how many patients are untreated but can afford therapy within each
territory-the true local measure of opportunity for pharmaceutical
companies
About Decision Resources
Decision Resources () is a world leader
in market research publications, advisory services and consulting designed
to help clients shape strategy, allocate resources and master their chosen
markets. Decision Resources is a Decision Resources, Inc. company.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that
offers best-in-class, high-value information and insights on important
sectors of the healthcare industry. Clients rely on this analysis and data
to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand or product names contained in this document may be
trademarks or registered trademarks of their respective holders.
Decision Resources

Buy viagra without prescription | Buy levitra without prescription | Buy propecia pills